Novo Nordisk A/S
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment pro…
Biotechnology
DK, Bagsvaerd [HQ]
NVO/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million DKK. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51,078.00 | 60,776.00 | 66,346.00 | 78,026.00 | 83,572.00 | 88,806.00 | 107,927.00 | 111,780.00 | 111,696.00 | 111,831.00 | 122,021.00 | 126,946.00 | 140,800.00 | 176,954.00 | 232,261.00 | |
|
EPS
|
3.59 | 4.96 | 6.05 | 7.82 | 9.40 | 10.10 | 13.56 | 7.50 | 7.71 | 7.98 | 8.20 | 9.03 | 10.40 | 12.26 | 18.67 | |
| Diluted in mil. | 3.56 | 4.92 | 6.00 | 7.77 | 9.35 | 10.07 | 13.52 | 7.48 | 7.70 | 7.97 | 8.19 | 9.00 | 10.37 | 12.22 | 18.62 | |
|
Profit
|
40,640.00 | 49,096.00 | 53,757.00 | 64,561.00 | 69,432.00 | 74,244.00 | 91,739.00 | 94,597.00 | 94,064.00 | 94,214.00 | 101,933.00 | 106,014.00 | 117,142.00 | 148,506.00 | 196,496.00 | |
| Gross Margin | 79.56 | 80.78 | 81.03 | 82.74 | 83.08 | 83.60 | 85.00 | 84.63 | 84.21 | 84.25 | 83.54 | 83.51 | 83.20 | 83.92 | 84.60 | |
| Pre Tax | 13,988.00 | 18,286.00 | 21,925.00 | 27,811.00 | 32,539.00 | 34,096.00 | 43,483.00 | 47,798.00 | 48,680.00 | 47,615.00 | 48,553.00 | 53,130.00 | 59,080.00 | 69,062.00 | 104,674.00 | |
| Profit Margin | 27.39 | 30.09 | 33.05 | 35.64 | 38.94 | 38.39 | 40.29 | 42.76 | 43.58 | 42.58 | 39.79 | 41.85 | 41.96 | 39.03 | 45.07 | |
| ETR | 23.02 | 21.23 | 22.02 | 22.94 | 22.60 | 22.33 | 19.83 | 20.66 | 21.67 | 18.87 | 19.78 | 20.69 | 19.17 | 19.60 | 20.05 | |
| Net | 10,768.00 | 14,403.00 | 17,097.00 | 21,432.00 | 25,184.00 | 26,481.00 | 34,860.00 | 37,925.00 | 38,130.00 | 38,628.00 | 38,951.00 | 42,138.00 | 47,757.00 | 55,525.00 | 83,683.00 | |
| Profit Margin | 21.08 | 23.70 | 25.77 | 27.47 | 30.13 | 29.82 | 32.30 | 33.93 | 34.14 | 34.54 | 31.92 | 33.19 | 33.92 | 31.38 | 36.03 | |
| EBITDA | 18,200.00 | 21,740.00 | 22,394.00 | 32,208.00 | 35,061.00 | 38,094.00 | 52,488.00 | 51,616.00 | 52,164.00 | 51,164.00 | 57,791.00 | 60,215.00 | 67,556.00 | 82,040.00 | 112,940.00 | |
| EBITDA Margin | 35.63 | 35.77 | 33.75 | 41.28 | 41.95 | 42.90 | 48.63 | 46.18 | 46.70 | 45.75 | 47.36 | 47.43 | 47.98 | 46.36 | 48.63 | |
| Operating Income | 14,933.00 | 18,891.00 | 22,374.00 | 29,474.00 | 31,493.00 | 34,492.00 | 49,444.00 | 48,432.00 | 48,967.00 | 47,248.00 | 52,483.00 | 54,126.00 | 58,644.00 | 74,809.00 | 102,574.00 | |
| Operating Margin | 29.24 | 31.08 | 33.72 | 37.77 | 37.68 | 38.84 | 45.81 | 43.33 | 43.84 | 42.25 | 43.01 | 42.64 | 41.65 | 42.28 | 44.16 | |
| Interest Income | 375.00 | 382.00 | 514.00 | 124.00 | 56.00 | 167.00 | 85.00 | 52.00 | 69.00 | 51.00 | 65.00 | 337.00 | 2,887.00 | 239.00 | 1,069.00 | |
| Loss | -36,486.00 | -43,199.00 | -44,466.00 | -48,552.00 | -52,079.00 | -54,314.00 | -58,483.00 | -63,348.00 | -62,729.00 | -64,583.00 | -69,538.00 | -72,820.00 | -82,156.00 | -102,145.00 | -129,687.00 | |
| Cost of Revenue | -10,438.00 | -11,680.00 | -12,589.00 | -13,465.00 | -14,140.00 | -14,562.00 | -16,188.00 | -17,183.00 | -17,632.00 | -17,617.00 | -20,088.00 | -20,932.00 | -23,658.00 | -28,448.00 | -35,765.00 | |
|
Operating Expenses
|
-26,048.00 | -31,519.00 | -31,877.00 | -35,087.00 | -37,939.00 | -39,752.00 | -42,295.00 | -46,165.00 | -45,097.00 | -46,966.00 | -49,450.00 | -51,888.00 | -58,498.00 | -73,697.00 | -93,922.00 | |
| R&D | -7,864.00 | -9,602.00 | -9,628.00 | -10,897.00 | -11,733.00 | -13,762.00 | -13,608.00 | -14,563.00 | -14,014.00 | -14,805.00 | -14,220.00 | -15,462.00 | -17,772.00 | -24,047.00 | -32,443.00 | |
| G&A | -2,764.00 | -3,722.00 | -3,245.00 | -3,312.00 | -3,508.00 | -3,537.00 | -3,857.00 | -3,962.00 | -3,784.00 | -3,916.00 | -4,007.00 | -3,958.00 | -4,050.00 | -4,467.00 | -4,855.00 | |
| SG&A | -18,184.00 | -21,917.00 | -22,249.00 | -24,856.00 | -26,888.00 | -26,760.00 | -32,169.00 | -32,339.00 | -32,124.00 | -33,313.00 | -35,830.00 | -36,886.00 | -41,058.00 | -50,684.00 | -61,598.00 | |
| S&M | -15,420.00 | -18,195.00 | -19,004.00 | -21,544.00 | -23,380.00 | -23,223.00 | -28,312.00 | -28,377.00 | -28,340.00 | -29,397.00 | -31,823.00 | -32,928.00 | -37,008.00 | -46,217.00 | -56,743.00 | |
| Depreciation and Amortization | -2,551.00 | -2,467.00 | - - | -2,693.00 | -2,799.00 | -3,435.00 | -2,959.00 | -3,193.00 | -3,182.00 | -3,925.00 | -5,661.00 | -5,753.00 | -6,025.00 | -7,362.00 | -9,413.00 | |
| Interest Expenses | -1,265.00 | -2,057.00 | -959.00 | -58.00 | -55.00 | -563.00 | -6,046.00 | -65.00 | -90.00 | -85.00 | -220.00 | -390.00 | -2,451.00 | -378.00 | -542.00 | |
| Other Expenses | -396.00 | -1,070.00 | -490.00 | -1,646.00 | -332.00 | -347.00 | -5,869.00 | -536.00 | -198.00 | -473.00 | -3,930.00 | -996.00 | -436.00 | -5,747.00 | -1,770.00 | |
|
WA Shares Outstanding
|
2,996.00 | 2,902.00 | 2,827.00 | 2,741.00 | 2,679.00 | 2,621.00 | 2,570.00 | 5,059.00 | 4,946.00 | 4,839.00 | 4,748.00 | 4,667.00 | 4,593.00 | 4,530.00 | 4,482.00 | |
| Diluted | 3,021.00 | 2,927.00 | 2,850.00 | 2,758.00 | 2,693.00 | 2,629.00 | 2,578.00 | 5,069.00 | 4,956.00 | 4,848.00 | 4,757.00 | 4,680.00 | 4,606.00 | 4,544.00 | 4,494.00 |